Arkolith/Insider Trading/CMPX/Form 4

Schuetz Thomas J.

CEO, DirectorCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed Jan 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2025Tax withholding(F)58K$1.86$108K6.5M

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-000195) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML